Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 0.9528
-2.78 %
$ 21.8 M
Market Cap
-1.19
P/E
CASH FLOW STATEMENT
-11.3 M
OPERATING CASH FLOW
-144 K
INVESTING CASH FLOW
20.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Femasys Inc.
| Net Income | -14.2 M |
| Depreciation & Amortization | 908 K |
| Capital Expenditures | -144 K |
| Stock-Based Compensation | 676 K |
| Change in Working Capital | 1.22 M |
| Others | 1.01 M |
| Free Cash Flow | -11.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (14.2) | (11.4) | (7.5) | (6.9) | (11.3) |
| Depreciation & Amortization | 0.9 | 0.9 | 1.0 | 1.1 | 1.1 |
| Deferred Income Tax | 0 | 0 | 3.64 K | 0 | 0 |
| Stock Based Compensation | 0.7 | 0.2 | 0.2 | 0.3 | 0.4 |
| Other Operating Activities | 0.2 | 6.38 K | (0.8) | 4.61 K | (0.1) |
| Change in Working Capital | 1.2 | (0.5) | (0.7) | 0.6 | (1.1) |
| Cash From Operations | (11.3) | (10.7) | (7.9) | (4.9) | (11.0) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.1) | (0.4) | (0.3) | 31.7 K | (0.7) |
| Other Items | 0 | 0 | 0 | 1.0 | 13.0 |
| Cash From Investing Activities | (0.1) | (0.4) | (0.3) | 1.0 | 12.3 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 6.2 | (0.5) | (0.5) | 0.8 | (0.1) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.4 | (0.2) | (1.6) | 78.2 K | 17.1 K |
| Cash From Financing Activities | 20.2 | (0.7) | 29.7 | 0.9 | (0.1) |
| CHANGE IN CASH | |||||
| Net Change In Cash | 8.8 | (11.8) | 21.5 | (3.1) | 1.2 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (11.4) | (11.1) | (8.2) | (5.0) | (11.7) |